Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1815-1818

  de Jonge, Evert ^a   Dekkers, Pascale E P ^b   Creasey, Abla A ^f   Hack, C Erik ^e   Paulson, Susan K ^g   Karim, Aziz ^g   Kesecioglu, Jozef ^a   Levi, Marcel ^c,d   van Deventer, Sander J H ^b   van der Poll, Tom ^b  

^a Department of Intensive Care ^*  (Netherlands)

^b Laboratory of Experimental Internal Medicine   (Netherlands)

^c Departments of Vascular Medicine   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

^f NOVARTIS PHARMA AG   (Switzerland)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ENDOTOXIN; PLACEBO; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; ENDOTOXEMIA; GRAM NEGATIVE INFECTION; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LEUKOCYTE; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ACUTE-PHASE REACTION; ADULT; ANTICOAGULANTS; BLOOD COAGULATION; CHEMOKINES; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; ENDOTOXEMIA; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; KINETICS; LEUKOCYTES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE;

EID: 0035876892     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320723     Document Type: Article

References (15)

1. Coagulation abnormalities in sepsis: Relation with inflammatory responses
2. Introduction: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
3. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
4. Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shock
5. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagùlopathic and lethal effects in the baboon gram-negative model of septic shock
6. Tissue factor pathway inhibitor (TFPI) dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
7. Enzyme immunoassay for factor VIII-related antigen
8. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro
9. Lipopolysaccharide toxicity-regulating proteins in bacteremia
10. Plasma elastase α-1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis
11. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
12. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
13. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
14. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells
15. New potential therapeutic modalities: A PC